Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Change in Working Capital
Abbott Laboratories
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Change in Working Capital
$-2.5B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
-7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Change in Working Capital
$170m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Change in Working Capital
$-771m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Change in Working Capital
$-526.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Change in Working Capital
$-535m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Change in Working Capital
$-777.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-43%
|
See Also
What is Abbott Laboratories's Change in Working Capital?
Change in Working Capital
-2.5B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Change in Working Capital amounts to -2.5B USD.
What is Abbott Laboratories's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-7%
Over the last year, the Change in Working Capital growth was -63%. The average annual Change in Working Capital growth rates for Abbott Laboratories have been -41% over the past three years , -76% over the past five years , and -7% over the past ten years .